{
  "generated": "2025-11-05T06:51:05.469479+00:00",
  "policy_fingerprint": "0x6036438e1b958d88",
  "source_evidence": "entries/neurological/omega-3-cog-omega-cog/cognition/v1/evidence.csv",
  "preferred_citation": "Kim G. TERVYX Protocol v1.0 (2025).",
  "studies": [
    {
      "study_id": "COG-OMEGA-COG_01",
      "year": 2005,
      "design": "randomized controlled trial",
      "journal": "cognition_journal",
      "outcome": "cognitive_decline",
      "population": "Adults with cognitive decline concerns",
      "adverse_events": "None reported",
      "doi": "10.1234/cog-omega-cog-01",
      "url": "https://doi.org/10.1234/cog-omega-cog-01",
      "citation": "COG-OMEGA-COG_01 (2005); Journal: cognition_journal; Design: randomized controlled trial; Population: Adults with cognitive decline concerns; Outcome: cognitive_decline; DOI: 10.1234/cog-omega-cog-01; Adverse Events: None reported."
    },
    {
      "study_id": "COG-OMEGA-COG_02",
      "year": 2006,
      "design": "randomized controlled trial",
      "journal": "cognition_journal",
      "outcome": "cognitive_decline",
      "population": "Adults with cognitive decline concerns",
      "adverse_events": "Mild GI discomfort",
      "doi": "10.1234/cog-omega-cog-02",
      "url": "https://doi.org/10.1234/cog-omega-cog-02",
      "citation": "COG-OMEGA-COG_02 (2006); Journal: cognition_journal; Design: randomized controlled trial; Population: Adults with cognitive decline concerns; Outcome: cognitive_decline; DOI: 10.1234/cog-omega-cog-02; Adverse Events: Mild GI discomfort."
    },
    {
      "study_id": "COG-OMEGA-COG_03",
      "year": 2007,
      "design": "randomized controlled trial",
      "journal": "cognition_journal",
      "outcome": "cognitive_decline",
      "population": "Adults with cognitive decline concerns",
      "adverse_events": "Transient headache",
      "doi": "10.1234/cog-omega-cog-03",
      "url": "https://doi.org/10.1234/cog-omega-cog-03",
      "citation": "COG-OMEGA-COG_03 (2007); Journal: cognition_journal; Design: randomized controlled trial; Population: Adults with cognitive decline concerns; Outcome: cognitive_decline; DOI: 10.1234/cog-omega-cog-03; Adverse Events: Transient headache."
    }
  ],
  "references": [
    {
      "type": "doi",
      "identifier": "10.1234/cog-omega-cog-01",
      "study_ids": [
        "COG-OMEGA-COG_01"
      ],
      "primary_study_id": "COG-OMEGA-COG_01",
      "url": "https://doi.org/10.1234/cog-omega-cog-01"
    },
    {
      "type": "doi",
      "identifier": "10.1234/cog-omega-cog-02",
      "study_ids": [
        "COG-OMEGA-COG_02"
      ],
      "primary_study_id": "COG-OMEGA-COG_02",
      "url": "https://doi.org/10.1234/cog-omega-cog-02"
    },
    {
      "type": "doi",
      "identifier": "10.1234/cog-omega-cog-03",
      "study_ids": [
        "COG-OMEGA-COG_03"
      ],
      "primary_study_id": "COG-OMEGA-COG_03",
      "url": "https://doi.org/10.1234/cog-omega-cog-03"
    }
  ],
  "manifest_hash": "sha256:a108c1c38a1e5d0f7b437034d13d54aec0dae5a4561a9076684cd2226e06fa5d"
}
